Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirvaso in Chronic Persistent Vascular Facial Erythema
NCT02856919Phase 4Completed
- Sponsor
- Galderma
- Start
- Jun 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Onreltea in rosacea, sponsored by Galderma. Started Jun 2016; status: completed.
02
Drugs
Onreltea
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02856919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856919.